Beam Therapeutics Inc (NASDAQ:BEAM)

Delayed Data
As of Nov 26
 -3.33 / -4.07%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 120.00, with a high estimate of 150.00 and a low estimate of 85.00. The median estimate represents a +52.71% increase from the last price of 78.58.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Beam Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -131.19%
Growthannually -40.79%


Growthquarterly 759.44%
Growthannually 53,122.22%
Key to the earnings and sales forecast charts.